ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,969Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 680

$1.54M Total Retail Price of All Prescriptions

Rank: 19 out of 680

1,248 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,248 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 1,248 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 18,128 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 831 757 1 2
LISINOPRIL 680 610 2 5
PRAVASTATIN SODIUM 639 599 3 10
OMEPRAZOLE 631 595 4 7
AMLODIPINE BESYLATE 597 558 5 1
ZOLPIDEM TARTRATE 481 461 6 17
HYDROCHLOROTHIAZIDE 472 436 7 9
ATORVASTATIN CALCIUM 415 396 8 11
METFORMIN HCL 402 349 9 8
FUROSEMIDE 383 339 10 6
ALPRAZOLAM 374 331 11 72
METOPROLOL TARTRATE 364 325 12 12
HYDROCODONE-ACETAMINOPHEN 357 324 S3 13 4
GABAPENTIN 281 267 14 15
SIMVASTATIN 271 252 15 3
ATENOLOL 266 259 16 19
TRAMADOL HCL 266 239 16 18
LOVASTATIN 257 249 18 44
AZITHROMYCIN 245 221 19 42
POTASSIUM CHLORIDE 236 227 20 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 206 185 21 37
AMLODIPINE BESYLATE-BENAZEPRIL 201 174 22 43
FLUTICASONE PROPIONATE 187 177 23 41
SERTRALINE HCL 186 155 24 28
LORAZEPAM 177 177 25 125
DIOVAN 175 164 26 31
DIOVAN HCT 173 158 27 55
NEXIUM 172 149 28 16
ALLOPURINOL 167 150 29 33
WARFARIN SODIUM 148 146 30 20
NAMENDA 143 143 31 35
CYMBALTA 140 124 32 46
METOPROLOL SUCCINATE 139 134 33 13
LOSARTAN-HYDROCHLOROTHIAZIDE 138 125 34 51
ALENDRONATE SODIUM 137 133 35 32
DIAZEPAM 135 128 36 188
CLONIDINE HCL 132 117 37 36
CLOPIDOGREL 126 121 38 26
PANTOPRAZOLE SODIUM 124 114 39 30
DONEPEZIL HCL 123 116 40 27
LOSARTAN POTASSIUM 123 103 40 21
TAMSULOSIN HCL 121 107 42 34
SYNTHROID 120 112 43 38
JANUVIA 118 114 44 60
PLAVIX 116 114 45 39
CELEBREX 112 101 46 90
ESCITALOPRAM OXALATE 110 108 47 45
MECLIZINE HCL 108 100 48 103
CITALOPRAM HBR 107 101 49 22
PROAIR HFA 102 70 50 67
CRESTOR 100 92 51 25
INSULIN SYRINGE 100 66 51 86
GLYBURIDE 100 90 R 51 85
FENOFIBRATE 98 97 54 66
TEMAZEPAM 96 93 55 155
LANTUS 95 85 56 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 83 57 94
SPIRIVA 91 87 58 70
BENICAR HCT 90 83 59 150
IRBESARTAN 88 85 60 247
BENAZEPRIL HCL 87 73 61 40
GLYBURIDE-METFORMIN HCL 86 82 R 62 107
CIPROFLOXACIN HCL 84 76 63 57
JANUMET 83 69 64 194
VIAGRA 71 61 65 214
ISOSORBIDE MONONITRATE ER 69 64 66 59
LUNESTA 68 55 67 252
DIGOXIN 66 65 68 58
AMITRIPTYLINE HCL 66 47 R 68 47
PREMARIN 66 65 R 68 105
CARTIA XT 65 60 71 307
DIPHENOXYLATE-ATROPINE 62 52 72 291
VERAPAMIL ER 60 46 73 100
COLCRYS 60 60 73 166
EVISTA 58 50 75 135
GEMFIBROZIL 58 49 75 106
TRIAMTERENE-HCTZ 57 57 77 52
GLIMEPIRIDE 56 52 78 29
LANSOPRAZOLE 54 48 79 184
IRBESARTAN-HYDROCHLOROTHIAZIDE 54 54 79 379
ADVAIR DISKUS 54 52 79 53
MELOXICAM 54 45 79 24
VENLAFAXINE HCL ER 53 28 83 101
CARVEDILOL 53 42 83 23
DICYCLOMINE HCL 52 44 85 278
BACLOFEN 52 31 85 140
TRADJENTA 52 52 85 301
ENALAPRIL MALEATE 52 38 85 65
LYRICA 51 44 89 77
BYSTOLIC 51 47 89 79
BENICAR 51 51 89 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.